HSBC Holdings’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,893
Closed -$11.5K 3202
2025
Q1
$11.5K Buy
12,893
+110
+0.9% +$153 ﹤0.01% 2981
2024
Q4
$21.7K Buy
12,783
+206
+2% +$371 ﹤0.01% 3049
2024
Q3
$24K Buy
+12,577
New +$28.6K ﹤0.01% 2940
2022
Q3
Sell
-445,142
Closed -$4.36M 3201
2022
Q2
$4.36M Hold
445,142
0.01% 1258
2022
Q1
$4.4M Buy
+445,142
New +$4.39M 0.01% 1230

Other funds holding PROK

HSBC Holdings's PROK Position: Q2 2025 in Review

HSBC Holdings sold out of ProKidney (PROK) in Q2 2025, closing a stake of 12,893 shares — an estimated $11.5K sold.

HSBC Holdings first reported a position in PROK in Q1 2022 and held it in 5 quarters. The position peaked at $4.4M in Q1 2022. 56 funds tracked by Wall St. Rank hold PROK as of Q2 2025.

  • HSBC Holdings reported no remaining ProKidney position as of Q2 2025 after selling out during the quarter.
  • HSBC Holdings sold 12,893 ProKidney shares in Q2 2025, an estimated $11.5K.
  • HSBC Holdings first reported a position in ProKidney in Q1 2022 and held it in 5 quarters.
  • HSBC Holdings's ProKidney position peaked at $4.4M in Q1 2022.
  • 56 funds tracked by Wall St. Rank held ProKidney as of Q2 2025.

Based on HSBC Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.